Amedisys, Inc. (NASDAQ:AMED) Short Interest Up 18.8% in November

Amedisys, Inc. (NASDAQ:AMED) saw a large increase in short interest in the month of November. As of November 30th, there was short interest totalling 2,590,000 shares, an increase of 18.8% from the November 15th total of 2,180,000 shares. Approximately 8.1% of the shares of the company are short sold. Based on an average trading volume of 488,500 shares, the days-to-cover ratio is presently 5.3 days.

Amedisys Stock Performance

Shares of NASDAQ:AMED traded up $0.08 during trading on Friday, hitting $85.68. The stock had a trading volume of 388,021 shares, compared to its average volume of 372,868. The company has a quick ratio of 1.19, a current ratio of 1.19 and a debt-to-equity ratio of 0.05. Amedisys has a 12-month low of $84.06 and a 12-month high of $98.95. The stock has a market capitalization of $2.81 billion, a price-to-earnings ratio of 34.00, a price-to-earnings-growth ratio of 1.84 and a beta of 0.73. The stock has a 50-day simple moving average of $92.66 and a two-hundred day simple moving average of $94.94.

Amedisys (NASDAQ:AMED) last announced its quarterly earnings results on Wednesday, November 6th. The health services provider reported $1.00 earnings per share for the quarter, missing the consensus estimate of $1.19 by ($0.19). Amedisys had a return on equity of 12.20% and a net margin of 3.57%. The company had revenue of $587.67 million for the quarter, compared to analyst estimates of $586.75 million. During the same period in the prior year, the business posted $0.98 earnings per share. Amedisys’s revenue for the quarter was up 5.7% on a year-over-year basis. On average, equities research analysts expect that Amedisys will post 4.45 earnings per share for the current fiscal year.

Hedge Funds Weigh In On Amedisys

Several institutional investors and hedge funds have recently modified their holdings of the business. Calamos Advisors LLC boosted its holdings in shares of Amedisys by 11.6% during the 2nd quarter. Calamos Advisors LLC now owns 397,347 shares of the health services provider’s stock worth $36,476,000 after purchasing an additional 41,220 shares during the last quarter. GAM Holding AG acquired a new stake in shares of Amedisys during the second quarter valued at about $275,000. Innealta Capital LLC purchased a new stake in shares of Amedisys in the 2nd quarter valued at approximately $64,000. Signaturefd LLC lifted its holdings in shares of Amedisys by 88.2% in the 2nd quarter. Signaturefd LLC now owns 1,131 shares of the health services provider’s stock worth $104,000 after acquiring an additional 530 shares during the last quarter. Finally, Commonwealth Equity Services LLC boosted its position in shares of Amedisys by 10.9% during the 2nd quarter. Commonwealth Equity Services LLC now owns 4,151 shares of the health services provider’s stock worth $381,000 after purchasing an additional 409 shares during the period. Hedge funds and other institutional investors own 94.36% of the company’s stock.

Amedisys Company Profile

Amedisys, Inc, together with its subsidiaries, provides healthcare services in the United States. It operates through three segments: Home Health, Hospice, and High Acuity Care. The Home Health segment offers a range of services in the homes of individuals for the recovery of patients from surgery, chronic disability, or terminal illness, as well as prevents avoidable hospital readmissions through its skilled nurses; nursing services, rehabilitation therapists specialized in physical, speech, and occupational therapy; and social workers and aides for assisting its patients.